Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation.
Genes in the major histocompatibility complex code for three major groups of glycoproteins, now referred to as classes I, II, and III. Susceptibility to some autoimmune diseases and to systemic lupus erythematosus is associated with the presence of particular haplotypes of genes in these three classes. An attempt has been made to correlate these finding on the basis of the observation that different polymorphic forms of complement component C4 show varying efficiencies of complement activation. It is suggested that susceptibility to these diseases will be related to the varying efficiency of complement cell lysis and of immune aggregate dissolution by complement. This in turn will depend on the strength of interaction of the different polymorphic forms of C4 with other proteins (some also polymorphic) in the scheme of activation and inactivation of complement. Such an arrangement would lead to preferential association of certain alleles of C2, C4 and factor B and possibly also of class I and II antigens as potential targets of complement reaction.
D000818:Animals; D001327:Autoimmune Diseases / Q000235:genetics; D003167:Complement Activation; D003172:Complement C1 / Q000235:genetics; D003175:Complement C2 / Q000235:genetics; D003176:Complement C3 / Q000235:genetics; D003181:Complement C4 / Q000235:genetics; D003165:Complement System Proteins / Q000235:genetics*; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D008285:Major Histocompatibility Complex; D051379:Mice; D011110:Polymorphism, Genetic; D011817:Rabbits; D012756:Sheep
D003172:Complement C1; D003175:Complement C2; D003176:Complement C3; D003181:Complement C4; D006680:HLA Antigens; D003165:Complement System Proteins